FDA
-
-
-
-
-
-
-
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
-
-
-
-
-
-
-
LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
-
-
-
-
-
-
-
LENSAR, Inc. (LNSR) Reports Q3 Loss of $0.64
-
322,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

